Results 111 to 120 of about 11,423 (147)

Preliminary identification of pathogenic variants in an Afro-Colombian Raizal family with risk factors for glaucoma. [PDF]

open access: yesColomb Med (Cali), 2022
Castillo-Plata H   +5 more
europepmc   +1 more source

Nuevo esteroide tópico en el tratamiento del edema macular

open access: yesRevista Cubana de Oftalmología
El pilar principal de tratamiento de las inflamaciones oculares tanto postquirúrgicas como endógenas, se basa en el uso de esteroides. Aunque estos medicamentos son efectivos, su empleo no está exento de riesgos como la hipertensión ocular y la ...
Ceija Molina Cisneros   +3 more
doaj  

[Necrotizing fasciitis: review and case report]. [PDF]

open access: yesRev Cient Odontol (Lima)
Martínez Venegas S   +2 more
europepmc   +1 more source

[Ophthalmic manifestations in patients recovered from COVID-19 in Mexico]. [PDF]

open access: yesArch Soc Esp Oftalmol, 2023
Hernández-Reyes FJ   +6 more
europepmc   +1 more source

[Etiology of low vision and blindness in seven reference centers in Colombia between the years 2012 to 2017Etiología da baixa visao e cegueira em sete centros de referencia na Colombia entre os anos de 2012 a 2017]. [PDF]

open access: yesRev Cuid, 2022
Suárez Escudero JC   +11 more
europepmc   +1 more source

[Tubercular panuveitis, can SARS-CoV-2 re-emerge opportunistic diseases?] [PDF]

open access: yesRev Esp Geriatr Gerontol, 2021
Gil García B   +5 more
europepmc   +1 more source

Effectiveness of Surgical Treatment on Survival of Patients with Malignant Pleural Mesothelioma. [PDF]

open access: yesCancers (Basel)
Báez-Saldaña R   +4 more
europepmc   +1 more source

[Aetiological diagnosis of dyspnoea using electrocardiogram]. [PDF]

open access: yesAten Primaria, 2020
Tarrazo Tarrazo C   +2 more
europepmc   +1 more source

[Pneumococcal meningitis in a tertiary care hospital: clinical characteristics, serotype distribution, and vaccination status]. [PDF]

open access: yesRev Esp Quimioter
Castellares-González CI   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy